April 02, 2025

HPV Testing Guidelines Updated for Head and Neck Carcinomas

New evidence expands recommendations for sinonasal squamous cell carcinoma and standardizes p16 immunohistochemistry interpretation.

Conexiant

April 02, 2025

Maternal Depression Affects Child's Eating Patterns

Early maternal depressive symptoms may hinder children's self-regulation and eating behaviors, according to a recent study.

Conexiant

April 02, 2025

Donanemab: Amyloid-Related Imaging Abnormalities

"ARIA is an adverse event associated with donanemab treatment that requires safety monitoring."

Conexiant

April 02, 2025

Do NSAIDs Prevent Dementia?

Long-term anti-inflammatory use linked to 12% reduced dementia risk in 14-year population study.

Conexiant

April 02, 2025

FDA Approves Automated Latent TB Test

Revvity’s Auto-Pure 2400 platform for use with the T-SPOT.TB test to automate latent tuberculosis diagnostics was approved by the FDA.

Conexiant

April 02, 2025

Herpes Zoster Vaccine May Lower Dementia Risk

"If these findings are truly causal, the zoster vaccine will be both far more effective as well as cost-effective in preventing or delaying dementia."

Conexiant

April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

April 01, 2025

GEM Helps Put T2D in Remission

Researchers highlight evidence-based lifestyle and pharmacologic strategies, including glycemic excursion minimization and tirzepatide, for early glycemic control in adults with type 2 diabetes.

Conexiant

April 01, 2025

FDA Approves Freeze-Dried Jynneos Vaccine

Bavarian Nordic’s freeze-dried Jynneos vaccine offers logistical advantages over the liquid-frozen version, supporting long-term U.S. stockpiling and public health preparedness.

Conexiant